glp-1 not injected Prescription GLP-1s for Weight Loss While many patients are seeing
Description
PMC NIH
SURMOUNT-5 trial: 2.6% mean weight loss Glapp users: 3.4% mean weight loss Relative improvement: +30.8% Week 12 Results Semaglutide weight loss comparison at 12 weeks: Glapp users achieved 7.5% vs 5.9% in SURMOUNT-5 trial
Rapid weight loss, especially in the early stages of treatment, can place stress on the body and temporarily disrupt hormonal balance, leading to more intense cramps or irregular periods
It mimics a natural hormone in your body to help regulate blood sugar, slow down digestion, and reduce appetiteall of which contribute to weight loss
The key lies in proactive digestion management and tweaking dietary habits
